ITM Power's Share Price and Operational Reality Diverge as Hydrogen Milestones Stack Up
Published on 08/15/2026 at 14:14 | Redaktion boerse-global.de
The gap between what ITM Power is achieving on the ground and what its share price is doing on the screen has rarely been wider. The Sheffield-based electrolyser specialist has spent the past month ticking off significant operational boxes — first green hydrogen flowing through a landmark German pipeline, then a hefty British government funding commitment — yet the equity has been drifting in the opposite direction.
Shares closed Friday at €1.27, down 3.1 percent on the day, leaving the stock roughly half its 52-week peak of €2.58 reached in late May. The retreat is all the more striking given the news flow: since the start of the year, the shares remain up 75 percent, which suggests the recent softness looks more like a pause for breath after a powerful rally than the start of something more sinister.
A German Corridor Comes Alive
The most tangible recent development came in early August when ITM Power confirmed that production had started at the GET H2 Nukleus electrolysis project in Lingen, Germany. The facility, operated by RWE, has begun feeding green hydrogen through a roughly 120-kilometre pipeline to the Chemiepark Marl, where Evonik stands ready as offtaker. ITM Power and Linde Engineering are supplying two 100-megawatt units to RWE for the project — a demonstration that the technology functions at industrial scale, and a signal that could carry weight with prospective large customers across Europe.
That operational milestone landed alongside a separate but equally significant development on the funding front. ITM Power secured a British government grant commitment of around £86.5 million for its Chronos electrolyser manufacturing facility — a package that breaks down into £46.5 million formally approved by the Department for Energy Security and Net Zero, supplemented by a £40 million equity participation from Great British Energy.
Analysts Split on the Story
The combination of a working German project and state backing at home prompted two houses to revise their numbers, though with notably different degrees of enthusiasm. Berenberg lifted its price target to 110 pence from 100 pence, retaining a buy recommendation. JPMorgan, by contrast, moved its target to 80 pence from 60 pence but kept a neutral stance — a markedly more cautious tone from the US bank.
Should investors sell immediately? Or is it worth buying ITM Power?
The market's reaction to all this has been muted at best. Friday's decline came without any company-specific negative catalyst beyond the company's own announcement on 4 August, and no further explanation for the drop was available in the reporting. The pullback has to be seen in context, however: neither the Lingen project nor the UK funding commitment has been called into question on the merits.
The Numbers That Matter
The fundamental picture is one of a business scaling rapidly but still burning cash at a meaningful rate. ITM Power reported record first-half revenue of £18 million for fiscal 2026, with the order book swelling to £152 million. Full-year guidance points to revenue between £35 million and £40 million, accompanied by an EBITDA loss of £27 million to £29 million — a reminder of just how capital-intensive the electrolyser business remains.
That guidance gap is the crux. The formal approval of grant funding is an important step, but it does not guarantee smooth operational execution; the journey from commitment to productive manufacturing capacity can take months, during which costs and timelines have a habit of shifting. The question investors are wrestling with is whether the order book converts into deliveries and revenue in the coming quarters, or whether the kind of production delays that have plagued the electrolyser sector before will put the targets at risk.
Volatility Remains the Constant
Technical indicators offer little comfort for those seeking clarity. The stock's annualised 30-day volatility stands at a striking 64 percent, making sharp daily moves like Friday's plausible even without a concrete negative trigger. The relative strength index sits at 47, signalling neither overbought nor oversold conditions — momentum is neutral at best, slightly bruised at worst.
On the positive side, the shares trade 14 percent above their 200-day moving average, which points to an intact medium-term uptrend. JPMorgan's Patrick Jones raised his target to 80 pence on 5 August, and Berenberg's more bullish 110 pence target with a buy rating provides a spread of views that reflects genuine uncertainty about the pace of execution.
What Comes Next
The next concrete test arrives with the quarterly numbers. Third-party calendars had flagged 12 August as a date for second-quarter 2026 results, though no accompanying release or trading update from the company itself was available at that point. Until hard figures land, the market will continue to weigh the operational progress in Lingen and the UK funding commitment as its primary reference points.
The medium-term bull case rests on ITM Power converting its grant funding into productive Chronos manufacturing capacity without significant slippage, and on the order book continuing to translate into revenue growth. The bear case is equally straightforward: losses that could reach £29 million against a revenue ceiling of £40 million underscore how far the business is from self-sufficiency, and any timeline slippage in the Chronos ramp-up or a breach of the communicated guidance would likely see the market price in the scepticism already visible in the gap from the year's high.
Ad
ITM Power Stock: New Analysis - 15 August
Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
